drugset / Trial / NCT00342563

Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients

NCT00342563

Phase 2 Completed 136 enrolled Yale University
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study will be to evaluate the efficacy of mecamylamine in reducing alcohol consumption in smoking and non-smoking alcohol dependent patients. We hypothesize that mecamylamine will result in a greater reduction of alcohol consumption than placebo. We further hypothesize that mecamylamine will be effective in reducing both alcohol consumption and smoking in a subset of alcoholics who also smoke.

Timeline

Start
2004-05
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Mecamylamine Small molecule 10 mg

Indications